Journal Article DKFZ-2018-00125

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Simultaneous whole-body18F-PSMA-1007-PET/MRI with integrated high-resolution multiparametric imaging of the prostatic fossa for comprehensive oncological staging of patients with prostate cancer: a pilot study.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2018
Springer-Verl. Heidelberg [u.a.]

European journal of nuclear medicine and molecular imaging 45(3), 340 - 347 () [10.1007/s00259-017-3854-6]
 GO

This record in other databases:  

Please use a persistent id in citations: doi:

Abstract: The aim of the present study was to explore the clinical feasibility and reproducibility of a comprehensive whole-body18F-PSMA-1007-PET/MRI protocol for imaging prostate cancer (PC) patients.Eight patients with high-risk biopsy-proven PC underwent a whole-body PET/MRI (3 h p.i.) including a multi-parametric prostate MRI after18F-PSMA-1007-PET/CT (1 h p.i.) which served as reference. Seven patients presented with non-treated PC, whereas one patient presented with biochemical recurrence. SUVmean-quantification was performed using a 3D-isocontour volume-of-interest. Imaging data was consulted for TNM-staging and compared with histopathology. PC was confirmed in 4/7 patients additionally by histopathology after surgery. PET-artifacts, co-registration of pelvic PET/MRI and MRI-data were assessed (PI-RADS 2.0).The examinations were well accepted by patients and comprised 1 h. SUVmean-values between PET/CT (1 h p.i.) and PET/MRI (3 h p.i.) were significantly correlated (p < 0.0001, respectively) and similar to literature of18F-PSMA-1007-PET/CT 1 h vs 3 h p.i. The dominant intraprostatic lesion could be detected in all seven patients in both PET and MRI. T2c, T3a, T3b and T4 features were detected complimentarily by PET and MRI in five patients. PET/MRI demonstrated moderate photopenic PET-artifacts surrounding liver and kidneys representing high-contrast areas, no PET-artifacts were observed for PET/CT. Simultaneous PET-readout during prostate MRI achieved optimal co-registration results.The presented18F-PSMA-1007-PET/MRI protocol combines efficient whole-body assessment with high-resolution co-registered PET/MRI of the prostatic fossa for comprehensive oncological staging of patients with PC.

Classification:

Contributing Institute(s):
  1. Radiologie (E010)
  2. Radiopharmazeutische Chemie (E030)
  3. Softwareentwicklung für Integrierte Diagnostik und Therapie(SIDT) (E071)
  4. KKE Nuklearmedizin (E060)
Research Program(s):
  1. 315 - Imaging and radiooncology (POF3-315) (POF3-315)

Appears in the scientific report 2018
Database coverage:
Medline ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; Ebsco Academic Search ; IF >= 5 ; JCR ; NCBI Molecular Biology Database ; SCOPUS ; Science Citation Index ; Science Citation Index Expanded ; Thomson Reuters Master Journal List ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > E010
Public records
Publications database

 Record created 2018-02-27, last modified 2024-02-29



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)